Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Faller

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Journal of Pharmaceutical Sciences|September 2, 1998
Caco-2 cell permeability of a new (hydroxybenzyl)ethylenediamine oral iron chelator: correlation with physicochemical properties and oral activityN Lowther, B Tomlinson, R Fox, et al.
Nephrologie|January 1, 1985
[Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis]J F Marichal, B Faller, C Mengus, et al.
Clinical Nephrology|November 13, 2008
Familial membranous glomerulopathy, toxic exposure and/or genetic sensibility?C Muller, F Alenabi, F Chantrel, et al.
Haemostasis|July 1, 1995
In vitro characterization of antithrombin III concentrates--a single-blind studyP Hellstern, U Moberg, M Ekblad, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1983
Progressive sclerosing peritonitis: a late and severe complication of maintenance peritoneal dialysisA Slingeneyer, C Mion, G Mourad, et al.
Clinical Nephrology|March 1, 1979
Continuous ambulatory peritoneal dialysis: a new era in the treatment of chronic renal failureD G Oreopoulos, M Robson, B Faller, et al.
L'Encephale|January 1, 1981
[Continuous ambulatory peritoneal dialysis in schizophrenia. Experimentation in 3 cases]J P Sichel, A Baldauf, M Horber, et al.
Nephrologie|January 1, 1985
[5 years of continuous ambulatory peritoneal dialysis (CAPD) (multicenter study of 345 patients)]C Verger, B Faller, J P Ryckelynck, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1992
Pharmacokinetics of cadralazine and its hydrazino-metabolite in patients with renal impairment after repeated administration of 5 mg once dailyJ F Marichal, P Brunel, J B Lecaillon, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1987
[Decentralization of the ARTEMIS system in a nephrology service in a general hospital]J F Marichal, C Devries, F Aimé, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Journal of Pharmaceutical Sciences|September 2, 1998
Caco-2 cell permeability of a new (hydroxybenzyl)ethylenediamine oral iron chelator: correlation with physicochemical properties and oral activityN Lowther, B Tomlinson, R Fox, et al.
Nephrologie|January 1, 1985
[Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis]J F Marichal, B Faller, C Mengus, et al.
Clinical Nephrology|November 13, 2008
Familial membranous glomerulopathy, toxic exposure and/or genetic sensibility?C Muller, F Alenabi, F Chantrel, et al.
Haemostasis|July 1, 1995
In vitro characterization of antithrombin III concentrates--a single-blind studyP Hellstern, U Moberg, M Ekblad, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1983
Progressive sclerosing peritonitis: a late and severe complication of maintenance peritoneal dialysisA Slingeneyer, C Mion, G Mourad, et al.
Clinical Nephrology|March 1, 1979
Continuous ambulatory peritoneal dialysis: a new era in the treatment of chronic renal failureD G Oreopoulos, M Robson, B Faller, et al.
L'Encephale|January 1, 1981
[Continuous ambulatory peritoneal dialysis in schizophrenia. Experimentation in 3 cases]J P Sichel, A Baldauf, M Horber, et al.
Nephrologie|January 1, 1985
[5 years of continuous ambulatory peritoneal dialysis (CAPD) (multicenter study of 345 patients)]C Verger, B Faller, J P Ryckelynck, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1992
Pharmacokinetics of cadralazine and its hydrazino-metabolite in patients with renal impairment after repeated administration of 5 mg once dailyJ F Marichal, P Brunel, J B Lecaillon, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1987
[Decentralization of the ARTEMIS system in a nephrology service in a general hospital]J F Marichal, C Devries, F Aimé, et al.
Pageof 8